BioSpace News Archive

The concept of company culture is a hot topic in the workplace now. Here are some tips to help you be more likable during an interview.

The trial evaluated margetuximab in patients with HER2-positive metastastic breast cancer who had already been treated with anti-HER2-targeted therapies.

Teijin Limited announced today its establishment of NOMON, Co., Ltd. to sell nutraceutical food and beverages that are scientifically proven to help people maintain their health.

Pharming Group N.V. presents its (unaudited) interim financial report for the first quarter ended 31 March 2019.

Bittium exhibits its products and solutions for neurophysiology at Post Cardiac Arrest Care 2019

Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates regarding its in-house discovered lenvatinib mesylate, eribulin mesylate, and MORAb-202 will be given at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, the United States, from May 31 to June 4, 2019.

MorphoSys AG today announced results from the primary analysis (cut-off date November 30, 2018) of the ongoing single-arm phase 2 clinical trial known as L-MIND.

Primary analysis of L-MIND trial of tafasitamab (MOR208) plus lenalidomide in relapsed or refractory (r/r) DLBCL confirms overall strong data reported previously from this trial

Financial terms of the deal were not disclosed, but Genentech aims to use Parvus’ technology to target IBD and Celiac.

Phase I clinical trial to evaluate safety and tolerability of ATR-002 in healthy volunteers